IRCT20260619069864N1 IRCT 2026-09-08 sheikh zayed hospital Comparative Efficacy of Levofloxacin versus Ceftriaxone and Azithromycin for Treating Community Acquired Pneumonia Comparative Efficacy of Levofloxacin versus Ceftriaxone and Azithromycin for Treating Community Acquired Pneumonia 2025-12-01 anticipated 150 Complete https://irct.ir/trial/91417 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Education/Guidance, Randomization description: Eligible participants who provide informed consent will be randomly allocated individually in a 1:1 ratio to either the levofloxacin group or the ceftriaxone plus azithromycin group. Simple randomization will be performed using a computer-generated random allocation sequence. The sequence will be generated before participant recruitment by an independent investigator who is not involved in recruitment or treatment. Sequentially numbered, opaque, sealed envelopes will be used for allocation concealment. After enrollment and baseline assessment, the next envelope in sequence will be opened to reveal the treatment assignment. N/A Community Acquired Pnemonia. Intervention 1: Intervention group: Levofloxacin 750 mg intravenously once daily for 5 days. Intervention 2: Control group: Ceftriaxone 1 g intravenously twice daily plus azithromycin 500 mg intravenously once daily for 5 days. No - There is not a plan to make this available Justification or reason for not sharing IPD is Deidentified individual participant data will not be shared because participant consent does not include unrestricted data sharing. To protect participant confidentiality and comply with institutional ethics requirements, there is no current plan to make the IPD publicly available.